Skip to main content
. 2022 May 21;22:299. doi: 10.1186/s12887-022-03344-9

Table 1.

Clinical and biochemical data of the study group

Mean ± SD/Median (IQR) Range
Clinical data
Age (years) 12.24 ± 3.04 5–17
Episodes of rejection 3.2 ± 1.4 0–6
Weight (kg) Pre KT 27.1 ± 10.48 12–50
Weight Pre KT SDS 0.46 (-0.68 – 1.77) -5.34- 4.04
Weight (kg) Post KT 39.46 ± 14.02 22—90
Weight Post KT SDS 0.78 ( 0.35 – 2.15) -2.6 – 4.1
Height (cm) Pre KT 115 ± 14.5 90- 145
Height Pre KT SDS -1.34 (-2.84 – -0.33) -4.59 – 4.97
Height (cm) Post KT 133 ± 17.18 95–157
Height Post KT SDS -1.49 (-2.31—0.69) -3.94 -2.49
BMI Pre KT (kg/m2) 21.34 ± 4.9 10–32
BMI Pre KT SDS 1.82 (0.68 – 2.63) -11.69 – 3.6
BMI Post KT (kg/m2) 28.5 ± 6.27 19- 48
BMI Post KT SDS 2.28 (1.67 – 2.83) 0.22 – 3.91
Systolic BP 121.14 ± 12.8 100–150
Diastolic BP 77.12 ± 9.2 60–95
Biochemical data
TGs (mg/dl) 148.08 ± 72.82 62 – 300
Cholesterol (mg/dl) 219.9 ± 48.89 120 – 330
HDL (mg/dl) 52.78 ± 13.65 27 – 70
LDL (mg/dl) 152.36 ± 30.74 70 – 250
FBG (mg/dl) 96.35 ± 11.2 80–119
2 h PPBG (mg/dl) 130.38 ± 27.9 83–179
HbA1c (%) 5.47 ± 0.45 4.8 – 7
Total (n = 50)
Number percentage
Cause of ESRD
Genetic FSGS 8 16%
Cystinosis 1 2%
Nephronophthisis 5 10%
CAKUT PUV 4 8%
VUR 9 18%
Neurogenic bladder 4 8%
Unknown Bilateral atrophic kidney 18 36%
Malignancy Wilm’s tumor 1 2%

*BMI Body Mass Index, SDS Standard Deviation Score, KT Kidney Transplantation, BP Blood Pressure, TG Triglycerides, HDL High Density Lipoprotein, LDL Low Density Lipoprotein, FBG Fasting Blood Glucose, PPBG Post Prandial Blood Glucose, HbA1c glycosylated Hemoglobin, FSGS Focal Segmental Glomeruloscelreosis, CAKUT Congenital Anomalies of the Kidney and Urinary Tract,PUV Posterior Urethral Valve,VUR Vesicourethral Reflux